Scarica l'app Stockscreener
15.53
3.54%
-0.57
Pre-mercato:
15.70
0.17
+1.09%
Jade Biosciences Inc Borsa (JBIO) Ultime notizie
UBS Initiates Jade Biosciences(JBIO.US) With Buy Rating, Announces Target Price $45 - Moomoo
UBS Initiates Jade Biosciences at Buy With $45 Price Target - Moomoo
UBS initiates Jade Biosciences stock at Buy on IgAN drug potential - Investing.com Canada
[Form 4] Jade Biosciences, Inc. Insider Trading Activity - Stock Titan
Jade Biosciences (JBIO) director granted 34,843 stock options at $15.22 strike price - Stock Titan
Jade Biosciences (JBIO) awards director 34,843 stock options at $15.22 - Stock Titan
Jade Biosciences (JBIO) director Erin Lavelle receives 34,843-share option grant - Stock Titan
Director Kiselak receives 34,843-share Jade Biosciences (JBIO) stock option grant - Stock Titan
Jade Biosciences (NASDAQ: JBIO) holders back charter and bylaw changes - Stock Titan
Jade Biosciences (JBIO) 10K Form and Latest SEC Filings 2026 - MarketBeat
Jade Biosciences Company Profile & Introduction - Moomoo
Fairmount funds lock up 19.99% stake in Jade Biosciences (JBIO) - Stock Titan
Jade Biosciences' JADE101 delivers deep IgA cuts, clearing path for kidney trials - MSN
Jade Biosciences Completes Public Offering of 11.5 Million Shares, Raising $172.5 Million for Autoimmune Disease Therapies - Moomoo
Jade Biosciences closes $172.5m public offering - scanx.trade
Jade Biosciences prices $150M public offering of common stock at $15/share - MSN
Jade Biosciences closes $172.5 million stock offering - Investing.com UK
Jade Biosciences closes $172.5 million stock offering By Investing.com - Investing.com South Africa
Jade Biosciences plans public offering, pre-funded warrants - MSN
Jade Biosciences Closes Public Offering of Shares - marketscreener.com
Jade Biosciences Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares - The Manila Times
Press Release: Jade Biosciences Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares - 富途牛牛
Number of shareholders of Jade Biosciences, Inc. – NASDAQ:JBIO - TradingView
Watkins Advises Jade Biosciences on Public Offering of Common Stock - Latham & Watkins LLP
Jade Biosciences Launches Major Underwritten Equity Offering - TipRanks
Jade Bios prices $150M follow-on offering, 10M shares at $15; nets ~$140.3M - TradingView
Jade Biosciences (NASDAQ: JBIO) prices $150M common stock sale - Stock Titan
Jade Biosciences (NASDAQ: JBIO) files prospectus for 10M-share $150M offering - Stock Titan
JADE101 Phase 1 Trial Marks Key Early Milestone for Jade Biosciences Investors - TipRanks
Wedbush Analyst Ratings On PRAX, IDYA, EWTX, JADE - RTTNews
Stock Market Today: S&P 500, Dow, Nasdaq Futures Fall As House Challenges Trump's Military Authority— Broadcom, CrowdStrike In Focus (UPDATED) - Benzinga
Why is Jade Biosciences stock sliding 9% today? By Investing.com - Investing.com India
Press Release: Jade Biosciences Announces Proposed Underwritten Public Offering - Moomoo
Jade Biosciences Prices $150 Million Public Offering - marketscreener.com
Stock Market Today: S&P 500 Futures Fall, Dow Gains As House Challenges Trump's Military Authority—Broadcom, CrowdStrike, Lululemon In Focus - Sahm
Jade Biosciences prices $150 million public offering at $15 By Investing.com - Investing.com Canada
Jade Biosciences stock falls on public offering announcement By Investing.com - Investing.com South Africa
Jade Biosciences: Jefferies, TD Cowen and UBS Are Joint Book-Running Managers for the Offering >JBIO - Moomoo
Press Release: Jade Biosciences Announces Pricing of Public Offering of Common Stock - Moomoo
Jade Biosciences stock falls on public offering announcement - Investing.com
Jade Biosciences prices $150 million public offering at $15 - Investing.com
Jade Biosciences Plans Public Offering - Moomoo
Jade Biosciences Announces Pricing of Public Offering of Common Stock - The Manila Times
Jade Biosciences Prices Public Offering Of 10 Million Shares at $15 Per Share - TradingView
Biotech Jade Biosciences prices $150M stock sale to fund autoimmune trials - Stock Titan
Jade Biosciences announces proposed public offering By Investing.com - Investing.com India
Jade Biosciences announces proposed public offering - Investing.com
1.27%
1.43%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):